Tech Company Financing Transactions

Autonomic Technologies Funding Round

Autonomic Technologies closed a $38 million Series D funding round on 5/12/2015. Backers included Edmond de Rothschild Investment Partners, Aberdare Ventures and Forbion Capital Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Medical Devices & Instruments

Mailing Address

355 Ravendale Dr.
Mountain View, CA 94043
USA

Phone

(650) 216-6107

Website

www.autonomictechnologies.com

Email Address

[email protected]

Overview

Autonomic Technologies, Inc. (ATI) is a medical device company focused on the development and commercialization of innovative therapies for the treatment of severe headache. The company's initial product, the ATI Neurostimulation System, is approved in Europe for the treatment of cluster headache.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Niamh Pellegrini

        

Chief Financial Officer

Nicola Downes

        

VP - Marketing

Ashlea Mittelstaedt

        

VP - Operations

Ian Welsford

        

VP - Sales

Olivier Taelman

        

Browse more venture capital transactions:

Prev: 5/12/2015: Atia Medical venture capital transaction
Next: 5/12/2015: DocuSign venture capital transaction

Share this article

About Our VC Transactions Data

We record every notable VC transaction. All VC database entries on this site come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary